Business Wire

Virtual Exhibitions of 23 Museums Lands on the Alipay Platform to Enhance Engagement with Mobile-Savvy Audience

18.5.2022 10:46:00 EEST | Business Wire | Press release

Share

On International Museum Day 2022, 4DAGE announced it landed virtual tours and exhibitions of 23 museums, including the historic Henan Museum and Zhejiang Provincial Museum in China and the Hetjens Museum in Germany, through a mini program on Alipay, the leading digital open platform. The collaboration between 4DAGE and Alipay provides China’s mobile-savvy audience an opportunity to better engage with and learn about the museums’ rich histories.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220518005528/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

A large bronze mask from China’s “Sanxingdui Ruins” displayed in the Sichuan Museum’s Bronze Age exhibition; from the virtual tour on the Alipay platform (Photo: Business Wire)

The mini program “Yunshang Mibao” (translated as “treasure hunting on the cloud”) launched on the Alipay platform provides users an immersive museum-visiting experience at their fingertips. They can appreciate the beauty of cultural relics in 3D and have a comprehensive tour of historical collections with Chinese narration.

These virtual exhibitions cover a wide range of subjects spanning 8,000 years of history, including Bronze Age civilization in the Yangtze river valley, dinosaurs in the Mesozoic Era and ceramics in the Rococo period.

“We are delighted to collaborate with museums and the Alipay platform to explore innovative ways to communicate the stories and histories of culture institutions to a wider range of museum and art lovers,” said Shen Ming, Director of International Cooperation from 4DAGE, the VR technology provider for the virtual tours.

“Alipay is committed to supporting the digital operations of brands and merchants to enhance their connection and engagement with consumers in China. Together with our partners, we are exploring digital solutions to meet museums’ evolving needs, including leveraging technology to bring their stories to a younger generation and open new commercialization opportunities,” said Xiaoqi Wang, Head of digital operations for culture and tourism sector at Alipay.

The partnership between 4DAGE and Alipay reflects Alipay’s continued commitment to help museums globally engage and deepen their relationship with China’s growing cultural arts and history community at time when international travel is affected by the COVID-19 pandemic.

To further celebrate this year’s International Museum Day, 28 Chinese museums are issuing newly launched creative digital collectibles on the Alipay mini program and the Topnod app, an Ant Group platform for collecting, exploring, and sharing digital collectibles.

A UNESCO report published in May 2020 showed the global museum industry has been severely impacted by COVID-19 with nearly 90% of museums worldwide closing their doors during the pandemic1. However, less than 20% of museum collections were available online, according to a report by the Network of European Museum Organisations in July 20202. Facing the pressing challenges brought by the pandemic, a growing number of museums start to leverage digital platforms and solutions, including online exhibitions, digital tours, and even livestreaming and blockchain technology powered digital collectibles, to better engage with museum lovers.

Including today’s announcement and a recent collaboration with nine Italian museums, over 2,000 museums have landed on the Alipay platform to enhance their digital operations and better connect with museum lovers. These museums are utilising at least one of the digital tools and services available on Alipay, such as mini programs, lifestyle accounts, and blockchain-powered digital collectibles.

About 4DAGE

Founded in 2014, 4DAGE has been dedicated to the studies and application of artificial intelligence in the field of three-dimensional digital reconstruction. As one of the first 3D digital reconstruction centers in China and one of the pioneering companies in 3D display technologies, 4DAGE provides products and solutions to major museums and expositions globally, including the Palace Museum, Nanchang Han Dynasty Haihunhou Historic Site Museum and World Expo. 4DAGE also serves industries ranging from industrial intelligence and smart city to real estate and new retail.

About Alipay

In the evolving digital era, Alipay has transformed from a payment tool of public trust to an open platform for businesses, institutions, service providers, and other partners. Business partners in various industries utilize Alipay to offer consumers a safe and convenient payment experience. Through digital operation, business partners can communicate and provide various commercial and daily life digital services for their clients via Alipay mini programs, lifestyle accounts, and IoT, along with other tools available. Currently, there have been over 80 million businesses serving more than 1 billion consumers via Alipay’s open platform services.

1 https://cimam.org/documents/102/Museums_around_the_world_in_the_face_of_COVID-19_-_UNESCO_Biblioteca_Digital.pdf
2 https://icom.museum/en/news/online-learning-teaching-digitised-collections/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Bell Wang
Email: yixing.wl@antgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye